Literature DB >> 25311585

The phenotypic variability of amyotrophic lateral sclerosis.

Bart Swinnen1, Wim Robberecht1.   

Abstract

Classic textbook neurology teaches that amyotrophic lateral sclerosis (ALS) is a degenerative disease that selectively affects upper and lower motor neurons and is fatal 3-5 years after onset--a description which suggests that the clinical presentation of ALS is very homogenous. However, clinical and postmortem observations, as well as genetic studies, demonstrate that there is considerable variability in the phenotypic expression of ALS. Here, we review the phenotypic variability of ALS and how it is reflected in familial and sporadic ALS, in the degree of upper and lower motor neuron involvement, in motor and extramotor involvement, and in the spectrum of ALS and frontotemporal dementia. Furthermore, we discuss some unusual clinical characteristics regarding presentation, age at onset and disease progression. Finally, we address the importance of this variability for understanding the pathogenesis of ALS and for the development of therapeutic strategies.

Entities:  

Mesh:

Year:  2014        PMID: 25311585     DOI: 10.1038/nrneurol.2014.184

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  107 in total

1.  DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

Authors:  Grazia Annesi; Giovanni Savettieri; Pierfrancesco Pugliese; Marco D'Amelio; Patrizia Tarantino; Paolo Ragonese; Vincenzo La Bella; Tommaso Piccoli; Donatella Civitelli; Ferdinanda Annesi; Brigida Fierro; Federico Piccoli; Gennarina Arabia; Manuela Caracciolo; Innocenza Claudia Cirò Candiano; Aldo Quattrone
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

2.  Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.

Authors:  M E Cudkowicz; D McKenna-Yasek; C Chen; E T Hedley-Whyte; R H Brown
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

Review 3.  The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  L Van Den Bosch; P Van Damme; E Bogaert; W Robberecht
Journal:  Biochim Biophys Acta       Date:  2006-05-17

4.  Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation.

Authors:  Satoshi Yamashita; Akira Mori; Hideya Sakaguchi; Tomohiro Suga; Daijirou Ishihara; Akihiko Ueda; Taro Yamashita; Yasushi Maeda; Makoto Uchino; Teruyuki Hirano
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

5.  White matter pathology in ALS and lower motor neuron ALS variants: a diffusion tensor imaging study using tract-based spatial statistics.

Authors:  Johannes Prudlo; Charlotte Bißbort; Aenne Glass; Annette Grossmann; Karlheinz Hauenstein; Reiner Benecke; Stefan J Teipel
Journal:  J Neurol       Date:  2012-02-21       Impact factor: 4.849

6.  Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study.

Authors:  Maaike M van der Graaff; Caroline A Sage; Matthan W A Caan; Erik M Akkerman; Cristina Lavini; Charles B Majoie; Aart J Nederveen; Aeilko H Zwinderman; Frans Vos; Frans Brugman; Leonard H van den Berg; Maarten C de Rijk; Pieter A van Doorn; Wim Van Hecke; Ronald R Peeters; Wim Robberecht; Stefan Sunaert; Marianne de Visser
Journal:  Brain       Date:  2011-02-28       Impact factor: 13.501

7.  Modelling the effects of penetrance and family size on rates of sporadic and familial disease.

Authors:  Ammar Al-Chalabi; Cathryn M Lewis
Journal:  Hum Hered       Date:  2011-08-12       Impact factor: 0.444

8.  Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis.

Authors:  Ryan Vass; Emily Ashbridge; Felix Geser; William T Hu; Murray Grossman; Dana Clay-Falcone; Lauren Elman; Leo McCluskey; Virginia M Y Lee; Vivianna M Van Deerlin; John Q Trojanowski; Alice S Chen-Plotkin
Journal:  Acta Neuropathol       Date:  2010-11-23       Impact factor: 17.088

9.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

10.  Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.

Authors:  Peter Green; Matthew Wiseman; Yanick J Crow; Henry Houlden; Shelley Riphagen; Jean-Pierre Lin; F Lucy Raymond; Anne-Marie Childs; Eamonn Sheridan; Sian Edwards; Dragana J Josifova
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

View more
  159 in total

Review 1.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

2.  Meta-analytic evaluation of the association between head injury and risk of amyotrophic lateral sclerosis.

Authors:  Yukari Watanabe; Takamitsu Watanabe
Journal:  Eur J Epidemiol       Date:  2017-10-27       Impact factor: 8.082

Review 3.  FTD and ALS--translating mouse studies into clinical trials.

Authors:  Lars M Ittner; Glenda M Halliday; Jillian J Kril; Jürgen Götz; John R Hodges; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2015-05-05       Impact factor: 42.937

Review 4.  Emerging mechanisms of molecular pathology in ALS.

Authors:  Owen M Peters; Mehdi Ghasemi; Robert H Brown
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

Review 5.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

Review 6.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

Review 7.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

8.  Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach.

Authors:  Robert Kueffner; Neta Zach; Maya Bronfeld; Raquel Norel; Nazem Atassi; Venkat Balagurusamy; Barbara Di Camillo; Adriano Chio; Merit Cudkowicz; Donna Dillenberger; Javier Garcia-Garcia; Orla Hardiman; Bruce Hoff; Joshua Knight; Melanie L Leitner; Guang Li; Lara Mangravite; Thea Norman; Liuxia Wang; Jinfeng Xiao; Wen-Chieh Fang; Jian Peng; Chen Yang; Huan-Jui Chang; Gustavo Stolovitzky
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 9.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

10.  Pearls & Oy-sters: The importance of atypical features and tracking progression in patients misdiagnosed with ALS.

Authors:  Ryan D Jacobson; Stephen A Goutman; Brian C Callaghan
Journal:  Neurology       Date:  2016-03-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.